Elixinol Wellness Ltd - Asset Resilience Ratio
Elixinol Wellness Ltd (EXL) has an Asset Resilience Ratio of 0.46% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Elixinol Wellness Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Elixinol Wellness Ltd's Asset Resilience Ratio has changed over time. See Elixinol Wellness Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Elixinol Wellness Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Elixinol Wellness Ltd (EXL) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$73.00K | 0.46% |
| Total Liquid Assets | AU$73.00K | 0.46% |
Asset Resilience Insights
- Limited Liquidity: Elixinol Wellness Ltd maintains only 0.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Elixinol Wellness Ltd Industry Peers by Asset Resilience Ratio
Compare Elixinol Wellness Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 48.48% |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
Drug Manufacturers - Specialty & Generic | 5.92% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Dermapharm Holding SE
XETRA:DMP |
Drug Manufacturers - Specialty & Generic | 1.23% |
|
China Animal Husbandry Industry Co Ltd
SHG:600195 |
Drug Manufacturers - Specialty & Generic | 3.81% |
|
Daewoong Pharma
KO:069620 |
Drug Manufacturers - Specialty & Generic | 0.19% |
|
Guizhou Bailing Group Pharmaceutical Co Ltd
SHE:002424 |
Drug Manufacturers - Specialty & Generic | 2.09% |
Annual Asset Resilience Ratio for Elixinol Wellness Ltd (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Elixinol Wellness Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.46% | AU$73.00K ≈ $51.65K |
AU$15.96 Million ≈ $11.30 Million |
-0.77pp |
| 2022-12-31 | 1.23% | AU$166.00K ≈ $117.46K |
AU$13.48 Million ≈ $9.54 Million |
+0.56pp |
| 2021-12-31 | 0.67% | AU$170.00K ≈ $120.29K |
AU$25.33 Million ≈ $17.92 Million |
+0.47pp |
| 2020-12-31 | 0.20% | AU$85.00K ≈ $60.14K |
AU$42.47 Million ≈ $30.05 Million |
-16.61pp |
| 2019-12-31 | 16.81% | AU$20.35 Million ≈ $14.40 Million |
AU$121.07 Million ≈ $85.66 Million |
-11.12pp |
| 2018-12-31 | 27.93% | AU$42.92 Million ≈ $30.37 Million |
AU$153.69 Million ≈ $108.75 Million |
+9.99pp |
| 2017-12-31 | 17.94% | AU$18.83 Million ≈ $13.33 Million |
AU$105.00 Million ≈ $74.30 Million |
-- |
| 2016-12-31 | 0.00% | AU$0.00 ≈ $0.00 |
AU$103.81 Million ≈ $73.45 Million |
-- |
| 2005-12-31 | 0.33% | AU$3.19 Million ≈ $2.26 Million |
AU$963.19 Million ≈ $681.52 Million |
-0.26pp |
| 2004-12-31 | 0.59% | AU$3.61 Million ≈ $2.56 Million |
AU$609.48 Million ≈ $431.25 Million |
-0.58pp |
| 2003-12-31 | 1.18% | AU$3.81 Million ≈ $2.69 Million |
AU$323.21 Million ≈ $228.69 Million |
-0.53pp |
| 2002-12-31 | 1.71% | AU$4.00 Million ≈ $2.83 Million |
AU$234.12 Million ≈ $165.66 Million |
-- |
About Elixinol Wellness Ltd
Elixinol Wellness Limited, a holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. The company offers its products under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributes its products through grocery, wholesale, and e-commerce c… Read more